I wonder, before Reduce-IT was approved, their annual sales were at n-level. Can we show use that as proof that anything above that level is de-facto upper limit for total addressable market for Marine indication? so anything beyond that (for all generics combined) is infringing?
News 
Market Data 
Discover 
AI
